ÂÜÀòÂÒÂ×

The Leadership Team at Eidos Therapeutics is responsible for guiding the strategic direction and operational execution of the company. Comprising seasoned biotechnology executives and co-founders, this team collaborates to drive the development of AG10, ensuring alignment with the company’s mission to improve the lives of patients with transthyretin amyloidosis. They focus on making critical decisions regarding research priorities, commercial strategy, and partnership opportunities to expedite the delivery of safe and effective therapies to market.